PIK3CA and head and neck squamous cell carcinoma: HNSCC cells proved to be sensitive and in vivo experiments showed dose-dependent growth inhibition in PIK3CA-mutated xenografts, indicating a superior effect in tumors with PIK3CA mutations [71].